Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"

NCT03954652 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03954652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03954652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2019
Completion date
October 1, 2022
Enrollment
1,350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic predisposition, rare diseases